Evaluation of a Screen and Treat Protocol for Influenza
NCT06207058
·
clinicaltrials.gov ↗
TERMINATED
Status
25
Enrollment
OTHER
Sponsor class
Stopped
Limited enrollment opportunities due to low rates of viral infections
Conditions
Influenza
Interventions
DRUG:
Baloxavir Marboxil
Sponsor
Tricore, Inc